Stokes—Adams Attacks in Bundle-branch Block

G. Bourne

DOI: https://doi.org/10.1136/BMJ.2.4951.1311

1955-11-26

British Medical Journal

Abstract:

What problem does this paper attempt to address?

Home blood pressure stability score is associated with better cardiovascular prognosis: data from the nationwide prospective J-HOP study

Kazuomi Kario,Hiroshi Kanegae,Satoshi Hoshide

DOI: https://doi.org/10.1038/s41440-024-01940-z

2024-10-13

Hypertension Research

Abstract:A home blood pressure (BP)-centered strategy is emerging as the optimal approach to achieve adequate BP control in individuals with hypertension, but a simple cardiovascular risk score based on home BP level and variability is lacking. This study used prospective data from the Japan Morning Surge-Home Blood Pressure (J-HOP) extended study to develop a simple home BP stability score for the prediction of cardiovascular risk. The J-HOP extended study included 4070 participants (mean age 64.9 years) who measured home BP three times in the morning and evening for 14 days at baseline. During the mean 6.3-year follow-up, there were 260 cardiovascular events. A home BP stability score was calculated based on the average of morning and evening systolic BP (SBP; MEave), and three home BP variability metrics: average real variability (average absolute difference between successive measurements); average peak (average of the highest three SBP values for each individual), and time in therapeutic range (proportion of time spent with MEave home SBP 100–135 mmHg). There was a curvilinear association between the home BP stability score and the risk of cardiovascular events. Compared with individuals in the optimal home SBP stability score group (9–10 points), those in the very high-risk group (0 points) had significantly higher cardiovascular event risk during follow-up (adjusted hazard ratio 3.97, 95% confidence interval 2.22–7.09; p < 0.001), independent of age, sex, medication, cardiovascular risk factors, and office BP. These data show the potential for a simple home BP-based score to predict cardiovascular event risk in people with hypertension.

peripheral vascular disease
Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice

Kazuomi Kario,Hiroshi Kanegae,Naoko Tomitani,Yukie Okawara,Takeshi Fujiwara,Yuichiro Yano,Satoshi Hoshide,on behalf of the J-HOP Study Group,

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.118.12740

IF: 9.8968

2019-10-07

Hypertension

Abstract:We developed an innovative automated home blood pressure (BP) monitoring method that measures BP while asleep repeatedly over several days. Our aim was to assess the predictive ability of nighttime BP obtained using the home BP device for incident cardiovascular disease (CVD) in general practice patients. We used data from the nationwide practice-based J-HOP (Japan Morning Surge–Home Blood Pressure) Nocturnal BP Study, which recruited 2545 Japanese with a history of or risk factors for CVD (mean age 63 years; antihypertensive medication use 83%). The associations between nighttime home BPs (measured at 2:00, 3:00, and 4:00 am using validated, automatic, and oscillometric home BP devices) and incident CVD, including coronary disease and stroke events, were assessed with Cox proportional hazards models. The mean±SD office, morning home, and nighttime home systolic BP (SBP)/diastolic BP were 140±15/82±10, 137±15/79±10, and 121±15/70±9 mm Hg, respectively. During a follow-up of 7.1±3.8 years (18,116 person-years), 152 CVD events occurred. A 10-mm Hg increase of nighttime home SBP was associated with an increased risk of CVD events (hazard ratios [95% CIs]: 1.201 [1.046–1.378]), after adjustments for covariates including office and morning home SBPs. The model fit assessed by the change in Goodness-of-Fit was improved when we added nighttime home SBP into the base models including office and morning home SBPs (Δ6.838 [5.6%]; P =0.009). This is among the first and largest nationwide practice-based study demonstrating that nighttime SBP obtained using a home device is a predictor of incident CVD events, independent of in-office and morning in-home SBP measurement. URL: http://www.umin.ac.jp/icdr/index.html . Unique identifier: UMIN000000894.

peripheral vascular disease
Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended

Kazuomi Kario,Naoko Tomitani,Takeshi Fujiwara,Yukie Okawara,Hiroshi Kanegae,Satoshi Hoshide

DOI: https://doi.org/10.1038/s41440-023-01297-9

2023-04-20

Hypertension Research

Abstract:While home blood pressure (BP) measurement is recommended for hypertension management, the clinical implications of peak home BP values have not been well studied. This study investigated the association between pathological threshold or frequency of peak home BP and cardiovascular events in patients with ≥1 cardiovascular risk factor. The Japan Morning Surge-Home Blood Pressure (J-HOP) study enrolled participants from 2005–2012 with extended follow-up from December 2017 to May 2018, which generated the dataset for this analysis. Average peak home systolic BP (SBP) was defined as average of the highest three BP values on 14-day measurement period. Patients were divided into quintiles of peak home BP, and the risk of stroke, coronary artery disease (CAD) and atherosclerotic cardiovascular disease (ASCVD; stroke+CAD) was determined. In 4231 patients (mean 65 years) followed for 6.2 years there were 94 strokes and 124 CAD events. The adjusted hazard ratio (HR) (95% CI) for the risk of stroke and ASCVD in patients with average peak home SBP in the highest versus lowest quintile was 4.39 (1.85–10.43) and 2.04 (1.24–3.36), respectively. Risk was greatest for stroke in the first 5 years: HR 22.66 (2.98–172.1). The pathological threshold of average peak home SBP for 5-year stroke risk was 176 mmHg. There was a linear association between the number of times peak home SBP > 175 mmHg and stroke risk. Peak home BP was a strong risk factor for stroke, especially within the first 5 years. We propose exaggerated peak home SBP > 175 mmHg as an early and strong novel risk factor for stroke.

peripheral vascular disease
[Treatment of osteoporosis with parathyroid hormone: evidence and perspective].

H. Kaji,T. Sugimoto

2005-04-01

Abstract:Parathyroid hormone (PTH) is a promising bone formation-stimulating agent, and the recent large-scale randomized controlled trial (RCT) revealed that parathyroid hormone increases and reduces lumbar bone mineral density and fracture risk, respectively, more potently than bisphosphonates. Moreover, PTH is also effective for male or glucocorticoid-induced osteoporosis. However, the recent studies showed that the co administration of PTH and bisphosphonate is not good. The further accumulation of evidence about the combined or subsequent therapy is expected.
Peak nocturnal home blood pressure as an early and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP Nocturnal BP study

Kazuomi Kario,Yukie Okawara,Hiroshi Kanegae,Naoko Tomitani,Satoshi Hoshide

DOI: https://doi.org/10.1038/s41440-024-01866-6

2024-09-06

Abstract:Clinical implications of high peak nighttime home blood pressure (BP) are currently unknown. This study investigated the association between peak nighttime home systolic BP (SBP) and cardiovascular events in individuals with at least one cardiovascular risk factor. In the Japan Morning Surge-Home Blood Pressure (J-HOP) study, nighttime home BP was automatically measured three times each night for 14 days at baseline using a nighttime home BP monitoring device (HEM-5001, Omron Healthcare). Peak nighttime home SBP was defined as average of the highest three values over the 14-night measurement period. Cardiovascular events (stroke, coronary artery disease, heart failure, aortic dissection) were tracked over a mean follow-up period of 7.1 years. This analysis included 2545 individuals (mean age 63.3 ± 10.3 years, 49% male). After adjusting for covariates (including age, sex, and average office, morning, evening, and nighttime home SBP), stroke risk was significantly higher in individuals with peak nighttime home SBP in the highest quintile (≥149.0 mmHg) compared to the lowest quintile (<119.3 mmHg) (hazard ratio [HR] 4.24, 95% confidence interval [CI] 1.07-16.77; p = 0.039 overall and 8.92, 1.49-53.43; p = 0.017 in the subgroup with ≥6 nighttime home SBP measurements). This increased stroke risk remained significant after controlling for day-by-day average real variability of nighttime BP. The average peak nighttime home SBP cut-off value for predicting an increased risk of incident stroke was 136 mmHg. We propose that exaggerated peak nighttime home SBP, determined from ≥6 measurements, is a novel risk factor for stroke, independent of conventional office and home BP values. The exaggerated peak nighttime home systolic blood pressure (HSBP) determined from six or more measurements as a novel risk factor for stroke, independent of conventional office and home blood pressure (BP) values.
Prediction of blood pressure variability using deep neural networks

Hiroshi Koshimizu,Ryosuke Kojima,Kazuomi Kario,Yasushi Okuno

DOI: https://doi.org/10.1016/j.ijmedinf.2019.104067

IF: 4.73

2020-04-01

International Journal of Medical Informatics

Abstract:PurposeThe purpose of our study was to predict blood pressure variability from time-series data of blood pressure measured at home and data obtained through medical examination at a hospital. Previous studies have reported the blood pressure variability is a significant independent risk factor for cardiovascular disease.MethodsWe adopted a standard deviation for a certain period and predicted the variability and mean values of blood pressure for 4 weeks using multi-input multi-output deep neural networks. In designing the prediction model, we prepared a dataset from a clinical study. The dataset included past time-series data for blood pressure and medical examination data such as gender, age, and others. As evaluation metrics, we used the standard deviation ratio (SR) and the root mean square error (RMSE). Moreover, we used cross-validation as the evaluation method.ResultsThe prediction performance of blood pressure variability and mean value after 1 to 4weeks showed a standard deviation ratio as variability metrics of "0.69" to "0.70", an RMSE of "5.04" to "6.65" mmHg, respectively. Additionally, our models were able to work for a participant with high variability in blood pressure values due to its multi-output nature.ConclusionThe results of this study show that our models can predict blood pressure over 4 weeks. Our models work for an individual with high variability of blood pressure. Therefore, we consider that our prediction models are valuable for blood pressure management.

health care sciences & services,computer science, information systems,medical informatics
Prediction of Intradialytic Blood Pressure Variation Based on Big Data

,Cheng-Jui Lin,Ying-Ying Chen,Pei-Chen Wu,Chi-Feng Pan,Hong-Mou Shih,Chih-Jen Wu

DOI: https://doi.org/10.1159/000527723

2023-03-09

Blood Purification

Abstract:Introduction: Cardiovascular (CV) events are the major cause of morbidity and mortality associated with blood pressure (BP) in hemodialysis (HD) patients. BP varies significantly during HD treatment, and the dramatic variation in BP is a well-recognized risk factor for increased mortality. The development of an intelligent system capable of predicting BP profiles for real-time monitoring is important. Our aim was to build a web-based system to predict changes in systolic BP (SBP) during HD. Methods: In this study, dialysis equipment connected to the Vital Info Portal gateway collected HD parameters that were linked to demographic data stored in the hospital information system. There were 3 types of patients: training, test, and new. A multiple linear regression model was built using the training group with SBP change as the dependent variable and dialysis parameters as the independent variables. We tested the model's performance on test and new patient groups using coverage rates with different thresholds. The model's performance was visualized using a web-based interactive system. Results: A total of 542,424 BP records were used for model building. The accuracy was greater than 80% in the prediction error range of 15%, and 20 mm Hg of true SBP in the test and new patient groups for the model of SBP changes suggested the good performance of our prediction model. In the analysis of absolute SBP values (5, 10, 15, 20, and 25 mm Hg), the accuracy of the SBP prediction increased as the threshold value increased. Discussion: This databae supported our prediction model in reducing the frequency of intradialytic SBP variability, which may help in clinical decision-making when a new patient receives HD treatment. Further investigations are needed to determine whether the introduction of the intelligent SBP prediction system decreases the incidence of CV events in HD patients. Blood Purif

hematology,urology & nephrology
Home Blood Pressure Monitoring: Current Status and New Developments

Kazuomi Kario

DOI: https://doi.org/10.1093/ajh/hpab017

2021-02-09

American Journal of Hypertension

Abstract:Abstract Home blood pressure monitoring (HBPM) is a reliable, convenient, and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM have dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. The accuracy and reliability of home blood pressure (BP) measurements require use of a validated device and standardized procedures, and good patient information and training. Key HBPM parameters include morning BP, evening BP, and the morning–evening difference. In addition, newer semi-automatic HBPM devices can also measure nighttime BP at fixed intervals during sleep. Advances in technology mean that HBPM devices could provide additional relevant data (e.g., environmental conditions) or determine BP in response to a specific trigger (e.g., hypoxia, increased heart rate). The value of HBPM is highlighted by a growing body of evidence showing that home BP is an important predictor of target organ damage, and cardiovascular disease (CVD)- and stroke-related morbidity and mortality, and provides better prognostic information than office BP. In addition, use of HBPM to monitor antihypertensive therapy can help to optimize reductions in BP, improve BP control, and reduce target organ damage and cardiovascular risk. Overall, HBPM should play a central role in the management of patients with hypertension, with the goal of identifying increased risk and predicting the onset of CVD events, allowing proactive interventions to reduce risk and eliminate adverse outcomes.

peripheral vascular disease
Day-to-day home blood pressure variability and risk of atrial fibrillation in a general Japanese population: the Hisayama Study

Akihiro Maezono,Satoko Sakata,Jun Hata,Emi Oishi,Yoshihiko Furuta,Mao Shibata,Tomomi Ide,Takanari Kitazono,Hiroyuki Tsutsui,Toshiharu Ninomiya

DOI: https://doi.org/10.1093/eurjpc/zwae035

IF: 8.526

2024-01-29

European Journal of Preventive Cardiology

Abstract:Abstract Aims Several prospective studies have reported that higher visit-to-visit blood pressure variability (BPV) is associated with atrial fibrillation (AF). However, no studies have investigated the association between day-to-day BPV assessed by home blood pressure measurement and the development of AF. Methods and results A total of 2829 community-dwelling Japanese aged ≥40 years without prior AF were followed up for 10 years (2007–17). Day-to-day home BPV [defined as coefficient of variation (CoV) of home systolic blood pressure (SBP) for 28 days] was categorized into four groups according to the quartiles: Q1, ≤ 4.64%; Q2, 4.65–5.70%; Q3, 5.71–7.01%; Q4, ≥ 7.02%. The hazard ratios for developing AF were estimated using a Cox proportional hazards model. During the follow-up period, 134 participants developed new-onset AF. The crude incidence rates of AF increased significantly with higher CoV levels of home SBP: 2.1, 4.9, 5.2, and 8.8 per 1000 person-years in the first, second, third, and fourth quartiles, respectively (P for trend < 0.01). After adjusting for potential confounders, increased CoV levels of home SBP were associated significantly with a higher risk of AF (P for trend = 0.02). The participants in the highest quartile of CoV had a 2.20-fold (95% confidence intervals: 1.18–4.08) increased risk of developing AF compared with those in the lowest quartile. Conclusion The present findings suggest that increased day-to-day home BPV levels are associated with a higher risk of the development of AF in a general Japanese population.

cardiac & cardiovascular systems
Proposal of reference value for day-to-day blood pressure variability based on two outcomes: the Ohasama study

Michihiro Satoh,Hirohito Metoki,Masahiro Kikuya,Takahisa Murakami,Yukako Tatsumi,Megumi Tsubota-Utsugi,Takuo Hirose,Azusa Hara,Kyoko Nomura,Kei Asayama,Atsushi Hozawa,Yutaka Imai,Takayoshi Ohkubo

DOI: https://doi.org/10.1097/hjh.0000000000003800

IF: 4.9

2024-08-29

Journal of Hypertension

Abstract:This study aimed to propose reference values for day-to-day home blood pressure (BP) variability that align with the established hypertension threshold of home BP for the risk of two different outcomes: cardiovascular mortality and cognitive decline.

peripheral vascular disease
[Ultrasonographic signs of congenital toxoplasmosis].

F. Jacquemard

IF: 1.82

2003-02-01

Archives de Pédiatrie

Abstract:
Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Takeshi Fujiwara,Yuichiro Yano,Satoshi Hoshide,Hiroshi Kanegae,Kazuomi Kario

DOI: https://doi.org/10.1001/jamacardio.2018.1233

2018-07-01

JAMA Cardiology

Abstract:Importance: The clinical outcomes associated with masked hypertension defined by home blood pressure monitoring (HBPM) in clinical settings remain uncertain.Objective: To assess the association between masked hypertension and cardiovascular disease events in clinical settings.Design, Setting, and Participants: This observational cohort study used data from 4261 outpatients treated at 71 primary practices or university hospitals throughout Japan who were enrolled in the Japan Morning Surge-Home Blood Pressure study between January 1, 2005, and December 31, 2012. Participants had a history of or risk factors for cardiovascular disease and were followed up through March 31, 2015. Participants underwent clinic blood pressure (BP) measurements on 2 occasions as well as HBPM measurements in the morning and evening for a 14-day period. Urine albumin to creatinine ratio and circulating brain (or B-type) natriuretic peptide levels were quantified at baseline as a marker of cardiovascular end-organ damage. Data were analyzed from July 1, 2017, to October 31, 2017.Exposures: Participants were categorized into 4 BP groups: (1) masked hypertension-hypertensive home BP levels (systolic, ≥135 mm Hg; diastolic, ≥85 mm Hg) and nonhypertensive clinic BP levels (systolic, <140 mm Hg; diastolic, <90 mm Hg); (2) white-coat hypertension-nonhypertensive home BP levels (systolic, <135 mm Hg; diastolic, <85 mm Hg) and hypertensive clinic BP levels (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg); (3) sustained hypertension-hypertensive home and clinic BP levels; and (4) controlled BP-nonhypertensive home and clinic BP levels.Main Outcomes and Measures: Incident stroke and coronary heart disease.Results: Of the 4261 participants, 2266 (53.2%) were women, 3374 (79.2%) were taking antihypertensive medication, and the mean (SD) age was 64.9 (10.9) years. During a median (interquartile range) follow-up of 3.9 (2.4-4.6) years, 74 stroke (4.4 per 1000 person-years) and 77 coronary heart disease (4.6 per 1000 person-years) events occurred. The masked hypertension group had a greater risk for stroke compared with the controlled BP group (hazard ratio, 2.77; 95% CI, 1.20-6.37), independent of traditional cardiovascular risk factors, urine albumin to creatinine ratio, and circulating B-type natriuretic peptide levels. Conversely, masked hypertension yielded no association with coronary heart disease risk.Conclusions and Relevance: In the Japanese general practice population, masked hypertension defined by HBPM may be associated with an increased risk for stroke events. Use of HBPM may improve the assessment of BP-related risks and identify new therapeutic interventions aimed at preventing cardiovascular disease events.

medicine, general & internal
Is calculation of a home blood pressure-based stability score a tool to improve risk stratification in clinical practice?

Tine Willum Hansen

DOI: https://doi.org/10.1038/s41440-024-02021-x

2024-11-20

Hypertension Research

Abstract:Hypertension Research, Published online: 14 November 2024; doi:10.1038/s41440-024-02021-x Is calculation of a home blood pressure-based stability score a tool to improve risk stratification in clinical practice?

peripheral vascular disease
Home Blood Pressure and Asymptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Enheng Cai,De-Wei An,Jin Zhang,Xiaofeng Tang,Yan Li,Yan Wang,Dingliang Zhu

DOI: https://doi.org/10.1101/2024.10.21.24315899

2024-10-22

Abstract:Background: We aim to analyze the effect of home blood pressure (HBP) level and variability on both asymptomatic intracranial (aICAS) and extracranial arterial stenosis (aECAS). Methods: A total of 534 patients completed HBP measurements (HBP) on at least 3 days. The stenoses of ICAS and ECAS were evaluated by CTA. HBP variability (HBPV) was quantified using the standard deviation and maximum--minimum difference between measures. The association of HBP level and variability with both aICAS and aECAS was evaluated using multivariate logistic regression. Results: Morning HBPV was significantly associated with isolated aICAS, isolated aECAS, and concurrent aICAS and aECAS, respectively, even after being adjusted for HBP level. Besides, HBP were independently related to concurrent aICAS and aECAS (P<0.05). Instead, neither morning nor evening HBP associated with isolated aICAS or aECAS. Conclusion: The findings of this study confirmed the strong correlation of aICAS/aECAS with HBP in the hypertensive population, particularly morning HBPV.
Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Pedro Guimarães,Andreas Keller,Michael Böhm,Lucas Lauder,Tobias Fehlmann,Luis M. Ruilope,Ernest Vinyoles,Manuel Gorostidi,Julián Segura,Gema Ruiz-Hurtado,Natalie Staplin,Bryan Williams,Alejandro de la Sierra,Felix Mahfoud

DOI: https://doi.org/10.1161/hypertensionaha.123.22529

IF: 9.8968

2024-04-27

Hypertension

Abstract:Hypertension, Ahead of Print. BACKGROUND:Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning–derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP).METHODS:The performance of the novel risk score was compared with existing risk scores, and the possibility of predicting ABP phenotypes utilizing clinical variables was assessed. Using data from 59 124 patients enrolled in the Spanish ABP Monitoring registry, machine-learning approaches (logistic regression, gradient-boosted decision trees, and deep neural networks) and stepwise forward feature selection were used.RESULTS:For the prediction of cardiovascular mortality, deep neural networks yielded the highest clinical performance. The novel mortality prediction models using OBP and ABP outperformed other risk scores. The area under the curve achieved by the novel approach, already when using OBP variables, was significantly higher when compared with the area under the curve of the Framingham risk score, Systemic Coronary Risk Estimation 2, and Atherosclerotic Cardiovascular Disease score. However, the prediction of cardiovascular mortality with ABP instead of OBP data significantly increased the area under the curve (0.870 versus 0.865;P=3.61×10−28), accuracy, and specificity, respectively. The prediction of ABP phenotypes (ie, white-coat, ambulatory, and masked hypertension) using clinical characteristics was limited.CONCLUSIONS:The receiver operating characteristic curves for cardiovascular mortality using ABP and OBP with deep neural network models outperformed all other risk metrics, indicating the potential for improving current risk scores by applying state-of-the-art machine learning approaches. The prediction of cardiovascular mortality using ABP data led to a significant increase in area under the curve and performance metrics.

peripheral vascular disease
Bipartite binomial heaps

Amr Elmasry,Claus Jensen,J. Katajainen

DOI: https://doi.org/10.1051/ita/2017010

2017-07-01

RAIRO - Theoretical Informatics and Applications

Abstract:We describe a heap data structure that supports Minimum, Insert, and Borrow at O (1) worst-case cost, Delete at O (lg n ) worst-case cost including at most lg n + O (1) element comparisons, and Union at O (lg n ) worst-case cost including at most lg n + O (lglg n ) element comparisons, where n denotes the (total) number of elements stored in the data structure(s) prior to the operation. As the resulting data structure consists of two components that are different variants of binomial heaps, we call it a bipartite binomial heap. Compared to its counterpart, a multipartite binomial heap, the new structure is simpler and mergeable, still retaining the efficiency of the other operations.
Home Monitoring of Heart Rate as a Predictor of Imminent Cardiovascular Events

Mikko P. Tulppo,Antti M. Kiviniemi,M. Juhani Junttila,Heikki V. Huikuri

DOI: https://doi.org/10.3389/fphys.2019.00341

IF: 4

2019-03-27

Frontiers in Physiology

Abstract:Introduction: Previous studies have documented that day-to-day variability of heart rate (HR) has prognostic significance for cardiovascular (CV) events in general population. It is unknown how HR dynamics variate before imminent CV event in patients with coronary artery disease (CAD). Our aim was to study day-to-day variation in HR dynamics before the occurrence of CV event in patients with initially stable CAD.Methods: Forty-four patients with angiographically documented CAD from ARTEMIS study measured R-R intervals on a weekly basis at home for 2 years. Home measurements were performed in controlled conditions (3 min at supine and sitting) 1–2 times per week. Eleven patients had a CV event (7 acute coronary syndromes, 1 cardiac death, 2 new onset of arrhythmia needing hospitalization and 1 stroke), which occurred 11 ± 7 months after enrolment. Mean R-R interval was analyzed prospectively from the home measurements. For the patients with new CV event, average, and standard deviation (SD) of the mean R-R interval over 8 weeks preceding the CV event were calculated. For the patients without new CV event, corresponding period was determined by the median follow-up at the occurrence of new CV event.Results: There were no differences in the mean R-R interval analyzed over 8 weeks between the patients with and without new CV event. The variability of mean R-R interval over 8 weeks was greater in the patients with new CV event compared to the patients without new CV event at the supine (95 ± 34 vs. 59 ± 26 ms, p < 0.001) and sitting positions (92 ± 28 vs. 62 ± 24 ms, p < 0.001).Conclusion: Day-to-day variability of mean R-R interval is greater before the new CV event in CAD patients suggesting to a more unstable cardiac autonomic regulation preceding these events.

physiology
PROGNOSTIC SIGNIFICANCE OF BLOOD PRESSURE FLUCTUATIONS IN THE MORNING AND EVENING FOR CARDIOVASCULAR OUTCOMES

Chi-Chen Cheng,Wei-Lun Chang,Shao-Yuan Chuang,Yu-Hsuan Lee,Chi-Jung Huang,Hao-Min Cheng,Chern-En Chiang,Chen-Huan Chen,Kei Asayama,Takayashi Ohkubo,Teemu J. Niiranen,José Boggia,Jan A. Staessen

DOI: https://doi.org/10.1097/01.hjh.0000941524.95432.1c

IF: 4.9

2023-06-01

Journal of Hypertension

Abstract:Independent of office blood pressure (BP) levels, home BP is associated with the occurrence of cardiovascular events. Abnormal diurnal variations in BP have been linked to cardiovascular disease (CVD). However, data on diurnal patterns of home BP, the morning and evening BP difference (MEdiff), are scarce. This study looked into the relationship between all MEdiff indices and cardiovascular outcomes. The association was assessed using data from the International Database of Home Blood Pressure in Relation to Cardiovascular Outcome (IDHOCO), which comprised 6753 patients from five cohorts. We found 1254 patients who had taken home BP readings every morning and every evening for more than 14 days. The MEdiff over a 13-day period, omitting the first day, for each patient were used to calculate the average (MEdiff_sbp_avg), minimum (MEdiff sbp_min), and maximum (MEdiff_sbp_max) values. MEdiff is defined as morning (6AM-8AM) minus evening BP (8PM-10PM) measures. The prognostic values of these parameters were assessed using Cox proportional hazards models. Factors adjusted in the base model included age, sex, body mass index, total cholesterol, high-density lipoprotein cholesterol, smoking status, prevalence of diabetes, history of cardiovascular disease, and antihypertensive drug treatment. Only MEdiff_min_sbp strongly predicted CVD (183 events; mean follow-up time of 13.4 years), but MEdiff_avg_sbp (hazard ratio: 0.906, 95% CI: 0.087-1.018 per SD), MEdiff_max_sbp (0.949, 0.846-1.064 per SD) did not. Spline regression analysis with thresholds of -17 mmHg and -4 mmHg revealed a U-curve association between MEdiff_min_sbp and the risk of CVD outcomes. Three groups were identified by MEdiff_min_sbp: lower than -17 mmHg (Low, n = 574), between -17 and -4 mmHg (medium, n = 568) and higher than -4 mmHg (high, n = 112). Compared to the low group, the high group had a significantly higher risk of CVD (1.353, 1.052-1.739), in the models with adjustment for the mean of the morning and evening SBP values, and MEdiff_avg_sbp or various BP variability indices. MEdiff_min_sbp was strongly associated with an increased risk of cardiovascular outcomes, suggesting that it could be a useful BP index for describing abnormal BP diurnal variations for CVD risk prediction.

peripheral vascular disease
Inconsistent Control Status of Office, Home, and Ambulatory Blood Pressure All Taken Using the Same Device: The HI-JAMP Study Baseline Data

Kazuomi Kario,Satoshi Hoshide,Naoko Tomitani,Masafumi Nishizawa,Tetsuro Yoshida,Tomoyuki Kabutoya,Takeshi Fujiwara,Hiroyuki Mizuno,Keisuke Narita,Takahiro Komori,Yukiyo Ogata,Daisuke Suzuki,Yukako Ogoyama,Akifumi Ono,Kayo Yamagiwa,Yasuhisa Abe,Jun Nakazato,Naoki Nakagawa,Tomohiro Katsuya,Noriko Harada,Hiroshi Kanegae

DOI: https://doi.org/10.1093/ajh/hpac103

2023-02-13

Abstract:Background: Inconsistencies between the office and out-of-office blood pressure (BP) values (described as white-coat hypertension or masked hypertension) may be attributable in part to differences in the BP monitoring devices used. Methods: We studied consistency in the classification of BP control (well-controlled BP vs. uncontrolled BP) among office, home, and ambulatory BPs by using a validated "all-in-one" BP monitoring device. In the nationwide, general practitioner-based multicenter HI-JAMP study, 2,322 hypertensive patients treated with antihypertensive drugs underwent office BP measurements and 24-hour ambulatory BP monitoring (ABPM), consecutively followed by 5-day home BP monitoring (HBPM), for a total of seven BP measurement days. Results: Using the thresholds of the JSH2019 and ESC2018 guidelines, the patients with consistent classification of well-controlled status in the office (<140 mmHg) and home systolic BP (SBP) (<135 mmHg) (n = 970) also tended to have well-controlled 24-hour SBP (<130 mmHg) (n = 808, 83.3%). The patients with the consistent classification of uncontrolled status in office and home SBP (n = 579) also tended to have uncontrolled 24-hour SBP (n = 444, 80.9%). Among the patients with inconsistent classifications of office and home BP control (n = 803), 46.1% had inconsistent ABPM-vs.-HBPM out-of-office BP control status. When the 2017 ACC/AHA thresholds were applied as an alternative, the results were essentially the same. Conclusions: The combined assessment of the office and home BP is useful in clinical practice. Especially for patients whose office BP classification and home BP classification conflict, the complementary clinical use of both HBPM and ABPM might be recommended.
Relationship between blood pressure repeatedly measured by a wrist-cuff oscillometric wearable blood pressure monitoring device and left ventricular mass index in working hypertensive patients

Kazuomi Kario,Naoko Tomitani,Tomoko Morimoto,Hiroshi Kanegae,Peter Lacy,Bryan Williams

DOI: https://doi.org/10.1038/s41440-021-00758-3

2021-10-17

Hypertension Research

Abstract:This study sought to evaluate the relationship between blood pressure (BP) taken by a new wrist-cuff oscillometric wearable BP monitoring device and left ventricular mass index measured by cardiac magnetic resonance imaging (cMRI-LVMI) in 50 hypertensive patients (mean age 60.5 ± 8.9 years, 92.0% men, 96% treated for hypertension) with regular employment. Participants were asked to self-measure their wearable BPs twice in the morning and evening under a guideline-recommended standardized home BP measurement, and once each at five predetermined times and any additional time points under an ambulatory condition for a maximum of 7 days. In total, 2105 wearable BP measurements (home BP: 747 [morning: 409, evening: 338], ambulatory condition: 1358 [worksite: 942]) were collected over 5.5 ± 1.2 days. The average of all wearable systolic BP (SBP) readings (129.8 ± 11.0 mmHg) was weakly correlated with cMRI-LVMI (r = 0.265, p = 0.063). Morning home wearable SBP average (128.5 ± 13.8 mmHg) was significantly correlated with cMRI-LVMI (r = 0.378, p = 0.013), but ambulatory wearable SBP average (132.5 ± 12.7 mmHg) was not (r = 0.215, p = 0.135). The averages of the highest three values of all wearable SBPs (153.3 ± 13.9 mmHg) and ambulatory wearable SBPs (152.9 ± 13.9 mmHg) were 16 mmHg higher than that of the morning home wearable SBPs (137.0 ± 15.9 mmHg). Those peak values were significantly correlated with cMRI-LVMI (r = 0.320, p = 0.023; r = 0.310, p = 0.029; r = 0.451, p = 0.002, respectively). In conclusion, an increased number of wearable BP measurements, which could detect individual peak BP, might add to the clinical value of these measurements as a complement to the guideline-recommended home BP measurements, but further studies are needed to confirm these findings.

peripheral vascular disease

Stokes—Adams Attacks in Bundle-branch Block

Home blood pressure stability score is associated with better cardiovascular prognosis: data from the nationwide prospective J-HOP study

Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice

Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended

[Treatment of osteoporosis with parathyroid hormone: evidence and perspective].

Peak nocturnal home blood pressure as an early and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP Nocturnal BP study

Prediction of blood pressure variability using deep neural networks

Prediction of Intradialytic Blood Pressure Variation Based on Big Data

Home Blood Pressure Monitoring: Current Status and New Developments

Day-to-day home blood pressure variability and risk of atrial fibrillation in a general Japanese population: the Hisayama Study

Proposal of reference value for day-to-day blood pressure variability based on two outcomes: the Ohasama study

[Ultrasonographic signs of congenital toxoplasmosis].

Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Is calculation of a home blood pressure-based stability score a tool to improve risk stratification in clinical practice?

Home Blood Pressure and Asymptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Bipartite binomial heaps

Home Monitoring of Heart Rate as a Predictor of Imminent Cardiovascular Events

PROGNOSTIC SIGNIFICANCE OF BLOOD PRESSURE FLUCTUATIONS IN THE MORNING AND EVENING FOR CARDIOVASCULAR OUTCOMES

Inconsistent Control Status of Office, Home, and Ambulatory Blood Pressure All Taken Using the Same Device: The HI-JAMP Study Baseline Data

Relationship between blood pressure repeatedly measured by a wrist-cuff oscillometric wearable blood pressure monitoring device and left ventricular mass index in working hypertensive patients